Danaher Corporation (DHR) Stock Forecasts

Argus

•

Jul 24, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$191.85

Price Target

Summary

Danaher is a diversified life sciences and diagnostics company with global operations. Its products and solutions support the biopharma industry in the development and production of therapies. Its Diagnostics segment provides clinical instruments, reagents, and consumables to

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Daily Spotlight: Flight to Quality for Dollar

Jul 24, 2026

•

RTX

Analyst Report: Edwards Lifesciences Corporation

Jul 24, 2026

•

EW

Analyst Report: RTX Corporation

Jul 24, 2026

•

RTX

Analyst Report: Roper Technologies, Inc.

Jul 24, 2026

•

ROP

Analyst Report: Honeywell International Inc.

Jul 23, 2026

•

HON

David H. Toung

Senior Analyst: Medical Devices & Healthcare Services

David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.